A Cross Sectional Study to Assess Liver Fibrosis in Patients with Diabetes and Metabolic Syndrome in India

Authors

  • Dr. Mohammed Ibrahim

Keywords:

liver fibrosis, enhanced liver fibrosis, non alcoholic fatty liver disease, cirrhosis, NAFLD fibrosis score

Abstract

Abstract not found

How to Cite

A Cross Sectional Study to Assess Liver Fibrosis in Patients with Diabetes and Metabolic Syndrome in India. (2016). Global Journal of Medical Research, 16(30), 17-22. https://medicalresearchjournal.org/index.php/GJMR/article/view/

References

S. Friedman (2003) Liver fibrosis - from bench to bedside. 38(Suppl. 1), S38-S53.

Wanless IR (2004) Pathogenesis of cirrhosis. 19, 369-71.

E. Brunt (2004) Nonalcoholic steatohepatitis, Semin. 24(1), 3-20. https://doi.org/10.1055/s-2004-823098

Ramón Bataller, Kari North, David Brenner (2003) Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal Hepatology. 37(3), 493-503. https://doi.org/10.1053/jhep.2003.50127

Maurizio Parola, Gaia Robino (2001) Oxidative stress-related molecules and liver fibrosis J Hepatol. 35(2), 297-306. https://doi.org/10.1016/s0168-8278(01)00142-8

Virginia Hernandez-Gea, Scott Friedman (2011) Pathogenesis of liver fibrosis. 6(1), 425-456. https://doi.org/10.1146/annurev-pathol-011110-130246

Bataller R, Brenner A.D (2005) Liver Fibrosis. 115, 209-218. https://doi.org/10.1172/JCI2005242

Nezam Afdhal (2003) Diagnosing Fibrosis in Hepatitis C: Is the Pendulum Swinging From Biopsy to Blood Tests?. 37(5), 972-974. https://doi.org/10.1053/jhep.2003.50223

Xie Q, Zhou X, Huang P, Wei J, Wang W (2014) The Performance of Enhanced Liver Fibrosis (ELF) Test for the Staging of Liver Fibrosis: A Meta- Analysis. 9(4), e92772. https://doi.org/10.1371/journal.pone.0092772

I. Hind, Fallatah (2014) Noninvasive Biomarkers of Liver Fibrosis: An Overview. 2014, 15. https://doi.org/10.1155/2014/3It57287

Chun-Tao Wai, Joel Greenson, Robert Fontana, John Kalbfleisch, Jorge Marrero, Hari Conjeevaram, Null- Lok (2003) A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C. 38(2), 518-526. https://doi.org/10.1053/jhep.2003.50346

Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S (2007) FIB- 4: an inexpensive and accurate marker of fibrosis in HCV infection comparison with liver biopsy and fibrotest. 46, 32-36. https://doi.org/10.1002/hep.21669

Masahiko Koda, Yoshiko Matunaga, Manri Kawakami, Yukihiro Kishimoto, Takeaki Suou, Yoshikazu Murawaki (2007) Fibroindex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. 45(2), 297-306. https://doi.org/10.1002/hep.21520

V. Mohan (2009) et al., Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome, Diab. https://doi.org/10.1016/j.diabres.2008;11.039

D. Amarapurkar, E. Hashimoto, L. Lesmana, D. Sollano, PJ, K. Goh, E. Gómez-Domínguez, J. Mendoza, S. Rubio, J. Moreno-Monteagudo, L. García-Buey, R. Moreno- Otero (2006) How and the Asiapacific working party on NAFLD C ommon is nonalcoholic fatty liver disease in the Asia-Pacific region and are there local differences? Journal of 22 Gómez-Domínguez E, Mendoza J, Rubio S, Moreno-Monteagudo JA, García-Buey L, Moreno- Otero R Transient elastography: a valid alternative to biopsy in patients with chronic liver disease Aliment Pharmacol Ther. 24, 513-518.

Zhiqiao Zhang, Gongsui Wang, Kaifu Kang, Guobiao Wu, Peng Wang (2016) The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection. 11(4), e0152757. https://doi.org/10.1371/journal.pone.0152757

Dvorak K, Stritesky J, Petrtyl J, Vitek L, Sroubkova R (2014) Use of Non-Invasive Parameters of Non-Alcoholic Steatohepatitis and Liver Fibrosis in Daily Practice - An Exploratory Case-Control Study. 9(10), e111551. https://doi.org/10.1371/journal.pone.0111551

V. Papastergiou, E. Tsochatzis, A. Burroughs (2012) Noninvasive assessment of liver fibrosis Annals of Gastroenterology. 25(3), 218-231.

S. Kalra, M. Vithalani, G. Gulati, C. Kulkarni, Y. Kadam, J. Pallivathukkal (2013) Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT) J Assoc Physicians India. 61, 448-453.

Halina Cichoż-Lach, A. Michalak (2014) Oxidative stress as a crucial factor in liver diseases World Journal of Gastroenterology : WJG. 20(25), 8082. https://doi.org/10.3748/wjg.v20.i25.8082

Hussein Atta (2015) Reversibility and heritability of liver fibrosis: Implications for research and therapy World Journal of Gastroenterology : WJG. 21(17), 5138. https://doi.org/10.3748/wjg.v21.i17.5138

A Cross Sectional Study to Assess Liver Fibrosis in Patients with Diabetes and Metabolic Syndrome in India

Published

2016-09-07

How to Cite

A Cross Sectional Study to Assess Liver Fibrosis in Patients with Diabetes and Metabolic Syndrome in India. (2016). Global Journal of Medical Research, 16(30), 17-22. https://medicalresearchjournal.org/index.php/GJMR/article/view/